Biomedical engineers have invented some of the most life-changing devices and therapies in modern medicine, from artificial organs that keep patients alive while awaiting transplants to gene-editing tools that fix diseases at the DNA level. Their work sits at the intersection of engineering and biology, and the results show up in nearly every hospital ward, pharmacy, and doctor’s office. Here’s a look at the most significant inventions to come out of the field.
Artificial Hearts
One of the most dramatic achievements in biomedical engineering is the total artificial heart. The SynCardia system, the most widely used version, is a pneumatically driven device that physically replaces both of the heart’s pumping chambers. It pushes blood through the body in a pulsating rhythm, mimicking the natural heartbeat, and serves as a bridge to keep patients alive until a donor heart becomes available.
A 20-year study tracking 196 patients at a single center found survival rates of 72% at one month, 41% at six months, and 34% at one year while on the device. About 35% of those patients went on to receive a successful heart transplant, and among that group, half were still alive a decade later. Those numbers reflect how dire the situation is for patients who need a total heart replacement, but also how effectively the device buys critical time.
MRI Scanners
Magnetic resonance imaging lets doctors see detailed pictures of soft tissue inside the body without radiation. The technology works by placing the body inside a powerful magnetic field, then using radio waves to excite hydrogen atoms in your tissues. Different tissue types respond differently, creating contrast that reveals tumors, torn ligaments, brain abnormalities, and organ damage with remarkable clarity.
Early research on MRI showed that image quality improves rapidly as magnetic field strength increases up to a certain point, with signal-to-noise levels rising steeply and then leveling off. Most of the diagnostic benefit is captured within a moderate field range, which is why the 1.5 and 3 Tesla machines found in most hospitals today hit the sweet spot between image quality, cost, and patient comfort. Higher-strength research scanners exist, but the gains for routine diagnosis diminish.
Cochlear Implants
Cochlear implants restored hearing for people with severe to profound deafness, something hearing aids alone cannot do. A hearing aid amplifies sound. A cochlear implant bypasses the damaged parts of the inner ear entirely, converting sound into electrical signals and delivering them directly to the auditory nerve through a thin electrode array threaded into the cochlea.
Modern implants use multiple electrodes spaced about a millimeter apart along this array. Each electrode stimulates a different region of the nerve, corresponding to different pitches of sound. The external processor worn behind the ear picks up sound, breaks it into frequency bands, and assigns each band to the appropriate electrode. The brain learns to interpret these electrical patterns as speech, music, and environmental sounds. Over 700,000 people worldwide have received cochlear implants, and many children implanted early enough develop spoken language on par with their hearing peers.
CRISPR Gene Editing
CRISPR is a tool that lets scientists cut and edit DNA at precise locations, and biomedical engineers played a central role in turning it from a laboratory curiosity into a medical therapy. The system uses a guide molecule to locate a specific gene sequence, then an enzyme to snip the DNA at that spot. The cell’s own repair machinery can then disable a harmful gene or allow a corrected version to take its place.
Clinical trials are now using CRISPR to treat sickle cell disease and beta-thalassemia, two inherited blood disorders. In sickle cell disease, a single mutation causes red blood cells to deform into a rigid crescent shape, blocking blood vessels and causing excruciating pain. The therapeutic approach edits a patient’s own blood stem cells to reactivate fetal hemoglobin, a form of the oxygen-carrying protein that doesn’t sickle. Early trial results have been strong enough to earn regulatory approval in several countries.
The pipeline extends well beyond blood disorders. Clinical trials are exploring CRISPR-based treatments for type 1 diabetes using gene-edited cell replacement therapy, for a hereditary form of amyloidosis by silencing a problematic liver gene, for high cholesterol by disrupting a gene that raises LDL levels, and even for HIV by targeting the virus’s DNA where it hides in human cells. Some of these approaches deliver the editing tool directly into the body using tiny fat particles called lipid nanoparticles, skipping the need to remove and re-infuse a patient’s cells.
Pulse Oximeters
The small clip placed on your finger during a doctor’s visit or hospital stay is a pulse oximeter, and it’s a biomedical engineering invention that became so routine it’s easy to forget how revolutionary it was. It measures blood oxygen saturation in real time, without drawing blood, by shining two wavelengths of light through your fingertip. Oxygenated hemoglobin absorbs infrared light at 940 nanometers, while deoxygenated hemoglobin absorbs red light at 660 nanometers. The ratio between the two tells the device exactly how much of your blood is carrying oxygen.
Before pulse oximetry, detecting low oxygen levels required arterial blood draws, which are painful and slow. Now a nurse can spot a dangerous drop in seconds. The device became especially visible during the COVID-19 pandemic, when patients used home pulse oximeters to monitor their oxygen levels and decide when to seek emergency care.
Continuous Glucose Monitors
For decades, people with diabetes had to prick their fingers multiple times a day to check blood sugar. Continuous glucose monitors changed that by using a tiny sensor inserted just under the skin that reads glucose levels in the fluid between cells, transmitting results to a phone or receiver every few minutes. This gives a complete picture of how blood sugar rises and falls throughout the day, not just snapshots.
Accuracy has improved steadily. In a real-world hospital study of the Dexcom G6, the device’s readings differed from laboratory blood tests by roughly 11 to 12% on average. That’s close enough to guide insulin dosing decisions for most patients in everyday life. When paired with an insulin pump, continuous monitors can form a “closed loop” system that automatically adjusts insulin delivery, functioning as a partial artificial pancreas. This combination has dramatically reduced dangerous overnight blood sugar drops for many people with type 1 diabetes.
Robotic Surgical Systems
Robotic surgery platforms like the da Vinci system let surgeons operate through tiny incisions using robotic arms that translate hand movements into precise, scaled-down motions inside the body. The surgeon sits at a console viewing a magnified 3D image of the surgical site while controlling instruments that can rotate and bend in ways the human wrist cannot.
The technology excels in procedures that demand fine work in tight spaces: prostate removal, hysterectomy, kidney surgery, and certain heart procedures. For patients, the smaller incisions typically mean less blood loss, less pain, and faster recovery compared to traditional open surgery. That said, robotic surgery isn’t universally superior. An analysis of 14 years of FDA safety data found that about 10% of reported events involved the procedure being interrupted to restart the system, convert to a non-robotic approach, or reschedule entirely. And for complex procedures like multi-vessel heart bypass, some highly experienced teams have found that the robotic approach can carry higher complication rates than open surgery. The benefits depend heavily on the procedure and the surgical team’s experience.
Myoelectric Prosthetic Limbs
Modern prosthetic arms and hands can be controlled by the wearer’s own muscle signals, a technology rooted in biomedical engineering. When you think about closing your hand, your brain sends electrical signals to the muscles in your forearm. Even after an amputation, the remaining muscles still produce these signals. Sensors on the surface of the prosthetic socket detect them and translate the signal’s strength into movement.
Simpler systems map a strong muscle contraction to one movement, like closing the hand, and a different contraction to another, like rotating the wrist. More advanced systems use pattern recognition: the prosthetic learns that a specific combination of muscle signals corresponds to a specific grip pattern, like pinching versus grasping. The most sophisticated versions skip pre-set patterns altogether and estimate hand position in real time using regression methods, allowing smoother, more natural control of multiple joints simultaneously.
Kidney Dialysis Machines
Dialysis machines keep over 2 million people alive worldwide by doing the job their kidneys can no longer perform: filtering waste and excess fluid from the blood. The core biomedical engineering challenge was designing a membrane that lets toxins and water pass through while keeping blood cells and essential proteins in the bloodstream.
Modern dialysis membranes are made from synthetic polymers like polysulfone, polyethersulfone, and polyacrylonitrile, chosen for their ability to filter precisely and their compatibility with human blood. Engineers further optimize these membranes by blending in hydrophilic additives that reduce the body’s inflammatory response when blood contacts the artificial surface. This matters because patients on hemodialysis typically undergo treatment three times a week for years, and every session exposes their blood to these materials. Reducing that inflammatory reaction has been one of the quieter but most meaningful advances in the field.
3D Bioprinted Tissue
Biomedical engineers are now using 3D printers loaded with living cells instead of plastic to build functional tissue. The most advanced work focuses on skin. Bioprinted skin models with multiple layers, including structures that mimic hair follicles and blood vessels, are already being used as drug testing platforms, reducing the need for animal testing in pharmaceutical development.
For burn patients, bioprinted skin grafts represent one of the most anticipated applications. Conventional wound dressings work well for superficial burns, but large, deep injuries overwhelm the body’s ability to heal and often require grafts harvested from elsewhere on the patient’s body. Bioprinting could eventually produce custom grafts on demand. The technology isn’t quite there yet for routine clinical use, as long-term stability hasn’t been fully established through large-scale trials, but the trajectory from lab bench to bedside is progressing steadily.